3D modelling of γδ T‐cell immunotherapy

3D modelling of γδ T‐cell immunotherapy

Bibliographic Details
Main Authors:	Caroline M. Hull, John Maher
Format:	Article
Language:	English
Published:	Wiley 2022-05-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.877

Similar Items

3D models for melanoma γδ T cell‐based immunotherapy
by: Veronica Huber MD, PhD, et al.
Published: (2022-06-01)

Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy
by: David M. Davies, et al.
Published: (2024-03-01)

γδ T Cell Immunotherapy—A Review
by: Hirohito Kobayashi, et al.
Published: (2015-02-01)

γδ T cells in immunotherapies for B-cell malignancies
by: Léa Rimailho, et al.
Published: (2023-06-01)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
by: Mahboubeh Yazdanifar, et al.
Published: (2020-05-01)

The emerging role of γδ T cells in cancer immunotherapy
by: Oliver Nussbaumer, et al.
Published: (2019-07-01)

γδ T cells as immunotherapy for malaria: balancing challenges and opportunities
by: Ana M. Vigário, et al.
Published: (2023-12-01)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
by: Rebecca E. Burnham, et al.
Published: (2020-11-01)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
by: Yi Hu, et al.
Published: (2023-11-01)

A close look at current γδ T-cell immunotherapy
by: Ling Ma, et al.
Published: (2023-03-01)

Biological characteristics of γδT cells and application in tumor immunotherapy
by: Renhong Zhu, et al.
Published: (2023-01-01)

γδ T cells: a sparkling star for clinical immunotherapy
by: Jiamian Zheng, et al.
Published: (2022-08-01)

Cancer immunotherapy using γδT cells: dealing with diversity
by: Wouter eScheper, et al.
Published: (2014-11-01)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
by: Elena Lo Presti, et al.
Published: (2017-10-01)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
by: Mateus de Souza Barros, et al.
Published: (2021-09-01)

Erratum: γδ T cells as immunotherapy for malaria: balancing challenges and opportunities
by: Frontiers Production Office
Published: (2024-01-01)

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
by: Derek Lee, et al.
Published: (2022-06-01)

Editorial: Next generation γδ T cell-based tumor immunotherapy
by: Andy Hee-Meng Tan, et al.
Published: (2022-09-01)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
by: Seino Ken-ichiro, et al.
Published: (2011-06-01)

Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
by: Megan Yuan, et al.
Published: (2024-03-01)

γδ T cells: Major advances in basic and clinical research in tumor immunotherapy
by: Yueqi Zhao, et al.
Published: (2024-01-01)

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
by: Stavros P. Papadakos, et al.
Published: (2024-01-01)

Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
by: Masatsugu Miyashita, et al.
Published: (2021-08-01)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
by: Yuan Song, et al.
Published: (2022-06-01)

The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
by: Yuxia Liu, et al.
Published: (2020-05-01)

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
by: Margarita Bartish, et al.
Published: (2020-09-01)

Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy
by: Isabella A Revesz, et al.
Published: (2024-01-01)

γδ T cells in 3D culture: The potential use in the therapeutics development
by: Shih‐Han Wang, et al.
Published: (2022-06-01)

The Aging of γδ T Cells
by: Weili Xu, et al.
Published: (2020-05-01)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
by: Ryunosuke Muro, et al.
Published: (2023-01-01)

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
by: Fabio Morandi, et al.
Published: (2020-07-01)

γδ T cells take the stage
by: Emily M Eriksson, et al.
Published: (2019-01-01)

The interaction of dendritic cells and γδ T cells promotes the activation of γδ T cells in experimental autoimmune uveitis
by: Beibei Wang, et al.
Published: (2017-03-01)

Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model
by: Jaquelyn T. Zoine, et al.
Published: (2019-08-01)

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells
by: Rushikesh Sudam Patil, et al.
Published: (2015-02-01)

Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy
by: Kawaljit Kaur, et al.
Published: (2024-01-01)

γδ T-cells in HIV infection
by: Holt NG, et al.
Published: (2012-09-01)

Editorial: γδ T Cells in Cancer
by: Seth B. Coffelt, et al.
Published: (2020-11-01)

Derivation of mimetic γδ T cells endowed with cancer recognition receptors from reprogrammed γδ T cell.
by: Jieming Zeng, et al.
Published: (2019-01-01)

Mycobacterium Vaccae Regulate γδT17 and γδTreg Cells in Mice Asthmatic Lung
by: Yien Yao, et al.
Published: (2022-09-01)